Becton Dickinson is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products.
Products that the company are known for include needles, syringes, needles, catheters, surgical blades and blood glucose monitors. Many of these products are used to deliver drugs and collect blood.
BD has offices in nearly 50 countries worldwide. The company's three major operating segments are Biosciences, Diagnostics and Medical.
In fiscal 2014, BD reported revenues of $8.44 billion, up from $8.05 billion, and net income of $1.18 billion.
BD announced in October 2014 it would buy healthcare products company CareFusion for $14 billion in cash.
Maxwell Becton and Fairleigh Dickinson met on a sales trip in 1897. Months later, they decided to go into business together, sealing their partnership with a handshake. They named their medical device import company Becton, Dickinson and Company.
On October 8, Becton made what is believed to be the company's first sale - a Luer all-glass syringe that sold for $2.50.
The company incorporated in NJ in 1906 and created a manufacturing facility in East Rutherford, the first in the U.S. built specifically for producing thermometers, hypodermic needles and syringes.
BD would go public on the NYSE in 1962. In 1999, the company decided to promote and market its name as BD.
- Accidental Death and Dismemberment Insurance
Updated February 5, 2015